Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.29
-0.01-0.07%
At close: -
$14.28
-0.01000-0.07%
After Hours: Jun 27, 6:50 PM EDT
Comments
Loading...
Elanco Animal Health Analyst Ratings and Price Targets | NYSE:ELAN | Benzinga
Elanco Animal Health Inc has a consensus price target of $15.55 based on the ratings of 12 analysts. The high is $20 issued by Morgan Stanley on November 15, 2022. The low is $9 issued by Goldman Sachs on April 25, 2023. The 3 most-recent analyst ratings were released by Stifel on May 19, 2025, May 8, 2025, and April 14, 2025, respectively. With an average price target of $14.67 between Stifel, there's an implied 2.64% upside for Elanco Animal Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Piper Sandler
UBS
Morgan Stanley
Barclays
1calculated from analyst ratings
Analyst Ratings for Elanco Animal Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2025 | Buy Now | — | William Blair | Brandon Vazquez67% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/19/2025 | Buy Now | 11.97% | Stifel | Jonathan Block72% | $15 → $16 | Maintains | Buy | Get Alert |
| 05/08/2025 | Buy Now | 4.97% | Stifel | Jonathan Block72% | $13 → $15 | Maintains | Buy | Get Alert |
| 04/14/2025 | Buy Now | -9.03% | Stifel | Jonathan Block72% | $15 → $13 | Maintains | Buy | Get Alert |
| 03/06/2025 | Buy Now | -16.03% | Piper Sandler | David Westenberg65% | $16 → $12 | Maintains | Neutral | Get Alert |
| 02/26/2025 | Buy Now | 18.96% | UBS | Andrea Alfonso65% | $18 → $17 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | -9.03% | Morgan Stanley | Erin Wright75% | $14 → $13 | Maintains | Equal-Weight | Get Alert |
| 02/26/2025 | Buy Now | 4.97% | Stifel | Jonathan Block72% | $16 → $15 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 32.96% | Barclays | Balaji Prasad55% | $20 → $19 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 11.97% | Stifel | Jonathan Block72% | $18 → $16 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | -2.03% | Morgan Stanley | Erin Wright75% | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 01/07/2025 | Buy Now | 25.96% | Stifel | Jonathan Block72% | $20 → $18 | Maintains | Buy | Get Alert |
| 12/09/2024 | Buy Now | 25.96% | UBS | Andrea Alfonso65% | → $18 | Initiates | → Buy | Get Alert |
| 12/02/2024 | Buy Now | -2.03% | Leerink Partners | Daniel Clark47% | → $14 | Initiates | → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | 39.96% | Barclays | Balaji Prasad55% | $19 → $20 | Maintains | Overweight | Get Alert |
| 10/28/2024 | Buy Now | 32.96% | Barclays | Balaji Prasad55% | $22 → $19 | Maintains | Overweight | Get Alert |
| 09/23/2024 | Buy Now | 53.95% | Barclays | Balaji Prasad55% | $21 → $22 | Maintains | Overweight | Get Alert |
| 09/19/2024 | Buy Now | 39.96% | Stifel | Jonathan Block72% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2024 | Buy Now | 4.97% | Morgan Stanley | Erin Wright75% | $17 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/01/2024 | Buy Now | 11.97% | Piper Sandler | David Westenberg65% | $19 → $16 | Maintains | Neutral | Get Alert |
| 06/28/2024 | Buy Now | 46.96% | Barclays | Balaji Prasad55% | $23 → $21 | Maintains | Overweight | Get Alert |
| 05/13/2024 | Buy Now | 32.96% | Piper Sandler | David Westenberg65% | $18 → $19 | Reiterates | Neutral → Neutral | Get Alert |
| 05/09/2024 | Buy Now | 60.95% | Barclays | Balaji Prasad55% | $19 → $23 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | 25.96% | Piper Sandler | David Westenberg65% | $12 → $18 | Reiterates | Neutral → Neutral | Get Alert |
| 02/27/2024 | Buy Now | -2.03% | Goldman Sachs | Nathan Rich42% | $12.5 → $14 | Maintains | Sell | Get Alert |
| 02/27/2024 | Buy Now | 18.96% | Morgan Stanley | Erin Wright75% | $16 → $17 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 32.96% | Barclays | Balaji Prasad55% | $18 → $19 | Maintains | Overweight | Get Alert |
| 01/17/2024 | Buy Now | -12.53% | Goldman Sachs | Nathan Rich42% | $10 → $12.5 | Maintains | Sell | Get Alert |
| 01/05/2024 | Buy Now | 39.96% | Stifel | Jonathan Block72% | $13 → $20 | Upgrade | Hold → Buy | Get Alert |
| 12/19/2023 | Buy Now | 18.96% | Jefferies | Glen Santangelo51% | → $17 | Initiates | → Buy | Get Alert |
| 12/15/2023 | Buy Now | 11.97% | Morgan Stanley | Erin Wright75% | → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/07/2023 | Buy Now | -9.03% | Stifel | Jonathan Block72% | $12 → $13 | Maintains | Hold | Get Alert |
| 11/13/2023 | Buy Now | -16.03% | Piper Sandler | David Westenberg65% | $11 → $12 | Maintains | Neutral | Get Alert |
| 11/08/2023 | Buy Now | 11.97% | Morgan Stanley | Erin Wright75% | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | Buy Now | -16.03% | Stifel | Jonathan Block72% | $13 → $12 | Maintains | Hold | Get Alert |
| 08/14/2023 | Buy Now | -9.03% | Piper Sandler | David Westenberg65% | $9 → $13 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -33.52% | Goldman Sachs | Nathan Rich42% | $8.5 → $9.5 | Maintains | Sell | Get Alert |
| 08/08/2023 | Buy Now | -33.52% | Goldman Sachs | Nathan Rich42% | $8.5 → $9.5 | Maintains | Sell | Get Alert |
| 04/26/2023 | Buy Now | -37.02% | Goldman Sachs | Nathan Rich42% | $10.5 → $9 | Maintains | Sell | Get Alert |
| 04/25/2023 | Buy Now | -37.02% | Goldman Sachs | Nathan Rice56% | $10.5 → $9 | Maintains | Sell | Get Alert |
| 04/20/2023 | Buy Now | -2.03% | Barclays | Balaji Prasad55% | → $14 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/22/2023 | Buy Now | -2.03% | Barclays | Balaji Prasad55% | $18 → $14 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | 32.96% | Morgan Stanley | Erin Wright75% | $20 → $19 | Maintains | Equal-Weight | Get Alert |
| 11/15/2022 | Buy Now | 39.96% | Morgan Stanley | Joseph Moore71% | $21 → $20 | Maintains | Equal-Weight | Get Alert |
| 11/14/2022 | Buy Now | 4.97% | Piper Sandler | David Westenberg65% | $21 → $15 | Maintains | Neutral | Get Alert |
| 11/09/2022 | Buy Now | -16.03% | Goldman Sachs | Nathan Rich42% | $19 → $12 | Maintains | Sell | Get Alert |
| 10/17/2022 | Buy Now | 39.96% | JP Morgan | Chris Schott59% | $24 → $20 | Maintains | Neutral | Get Alert |
| 10/07/2022 | Buy Now | 46.96% | Morgan Stanley | Joseph Moore71% | $22 → $21 | Maintains | Equal-Weight | Get Alert |
| 09/12/2022 | Buy Now | 25.96% | Barclays | Balaji Prasad55% | $32 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/18/2022 | Buy Now | 53.95% | Morgan Stanley | Erin Wright75% | $37 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/17/2022 | Buy Now | 46.96% | Piper Sandler | David Westenberg65% | $22 → $21 | Maintains | Neutral | Get Alert |
| 08/16/2022 | Buy Now | — | JP Morgan | Chris Schott59% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/21/2022 | Buy Now | 32.96% | Goldman Sachs | Nathan Rich42% | $32 → $19 | Downgrade | Buy → Sell | Get Alert |
| 07/18/2022 | Buy Now | 123.93% | JP Morgan | Chris Schott59% | $37 → $32 | Maintains | Overweight | Get Alert |
| 07/12/2022 | Buy Now | 53.95% | Piper Sandler | David Westenberg65% | → $22 | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Elanco Animal Health (ELAN) stock?
The latest price target for Elanco Animal Health (NYSE:ELAN) was reported by William Blair on June 26, 2025. The analyst firm set a price target for $0.00 expecting ELAN to fall to within 12 months (a possible -100.00% downside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Elanco Animal Health (ELAN)?
The latest analyst rating for Elanco Animal Health (NYSE:ELAN) was provided by William Blair, and Elanco Animal Health upgraded their outperform rating.
When was the last upgrade for Elanco Animal Health (ELAN)?
The last upgrade for Elanco Animal Health Inc happened on June 26, 2025 when William Blair raised their price target to N/A. William Blair previously had a market perform for Elanco Animal Health Inc.
When was the last downgrade for Elanco Animal Health (ELAN)?
The last downgrade for Elanco Animal Health Inc happened on September 19, 2024 when Morgan Stanley changed their price target from $17 to $15 for Elanco Animal Health Inc.
When is the next analyst rating going to be posted or updated for Elanco Animal Health (ELAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elanco Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elanco Animal Health was filed on June 26, 2025 so you should expect the next rating to be made available sometime around June 26, 2026.
Is the Analyst Rating Elanco Animal Health (ELAN) correct?
While ratings are subjective and will change, the latest Elanco Animal Health (ELAN) rating was a upgraded with a price target of $0.00 to $0.00. The current price Elanco Animal Health (ELAN) is trading at is $14.29, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
